insights_auto
Why is RCEL up 5.02%?
Dive Deeperchevron_right
RCEL:NASDAQ
AVITA Medical Inc
$13.80
arrow_upward
+5.02%(+0.66) 1D
$13.98
arrow_upward
+1.30% (+0.18)bedtimeAfter hours
Closed: Oct 20, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RCEL...
Open
$13.29
High
$14.08
Low
$13.29
Mkt. cap
426.79M
Avg. vol.
321.85K
Volume
0.00
52-wk high
$14.08
52-wk low
$3.22
EPS
-$1.44
Beta
1.99
Shares outstanding
30.93M
No. of employees
226
Open
$13.29
High
$14.08
Low
$13.29
Mkt. cap
426.79M
Avg. vol.
321.85K
Volume
0.00
52-wk high
$14.08
52-wk low
$3.22
EPS
-$1.44
Beta
1.99
Shares outstanding
30.93M
No. of employees
226
News stories
From web sources and news partners
scanx.trade
·
10 hours ago
Avita Medical Q3FY26 Results: Earnings call set for November 5
Yahoo Finance
·
11 hours ago
AVITA Medical to Announce Third Quarter 2026 Financial Results
Simply Wall Street
·
1 day ago
What Comes Next For AVITA Medical After A 276% Gain
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorBiotechnology
Websiteavitamedical.com